Pregnancy: Pregnancy Category D: Teratogenesis, reproduction, and fertility studies as well peri- and post-natal studies did not reveal any specific toxic effect. Nevertheless, as in animal toxicology studies with the 24 mg/kg dose, a mild delay in the body weight increase and in growth has been observed. As levodropropizine is able to cross the placental barrier in rats, it is contraindicated in women wanting to get pregnant or already pregnant as its safety of use is not documented.
Lactation: Studies in rats show that levodropropizine can be found in the mother's milk until 8 hours after administration. Levodropropizine is contraindicated during lactation.
Other Services
Country
Account